Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic antagonist drugs
- PMID: 2687921
- DOI: 10.1007/BF00445560
Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic antagonist drugs
Abstract
Performance on the radial-arm maze depends on the integrity of both cholinergic and dopaminergic systems. We have previously found that administration of either the nicotinic-cholinergic antagonist, mecamylamine, or the muscarinic-cholinergic antagonist, scopolamine, impairs choice accuracy in the radial-arm maze. Co-administration of the dopaminergic antagonist, haloperidol, ameliorated the performance deficit caused by scopolamine but exacerbated the deficit caused by mecamylamine. Furthermore, antagonism of the effect of scopolamine is due specifically to blockade of D1 receptors. In the present experiment behaviorally subthreshold doses of mecamylamine and the D2 antagonist raclopride impaired maze performance when administered together. No interactive effects were observed between mecamylamine and the D1 antagonist SCH 23390. Although several of the drug treatments studied significantly increased choice latency, an index of motor behavior, there was no perfect relationship between choice accuracy and choice latency. These data indicate that nicotinic-cholinergic and muscarinic-cholinergic systems interact selectively and differentially with D1 and D2 dopaminergic systems.
Similar articles
-
Nicotinic-dopaminergic relationships and radial-arm maze performance in rats.Behav Neural Biol. 1989 Jul;52(1):78-86. doi: 10.1016/s0163-1047(89)90182-9. Behav Neural Biol. 1989. PMID: 2757586
-
Characterization of the cognitive effects of combined muscarinic and nicotinic blockade.Behav Neural Biol. 1990 Jan;53(1):103-12. doi: 10.1016/0163-1047(90)90865-4. Behav Neural Biol. 1990. PMID: 1967931
-
Scopolamine interactions with D1 and D2 antagonists on radial-arm maze performance in rats.Behav Neural Biol. 1988 Sep;50(2):240-5. doi: 10.1016/s0163-1047(88)90911-9. Behav Neural Biol. 1988. PMID: 2906537
-
Cholinergic-dopaminergic interactions in cognitive performance.Behav Neural Biol. 1990 Nov;54(3):271-99. doi: 10.1016/0163-1047(90)90639-n. Behav Neural Biol. 1990. PMID: 2078161 Review.
-
Acute and chronic nicotinic interactions with dopamine systems and working memory performance.Ann N Y Acad Sci. 1995 May 10;757:245-52. doi: 10.1111/j.1749-6632.1995.tb17481.x. Ann N Y Acad Sci. 1995. PMID: 7611680 Review.
Cited by
-
Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization.Psychopharmacology (Berl). 2006 Mar;184(3-4):523-39. doi: 10.1007/s00213-005-0164-7. Epub 2005 Oct 12. Psychopharmacology (Berl). 2006. PMID: 16220335 Review.
-
Chronic nicotine working and reference memory effects in the 16-arm radial maze: interactions with D1 agonist and antagonist drugs.Psychopharmacology (Berl). 1996 Sep;127(1):25-30. doi: 10.1007/BF02805971. Psychopharmacology (Berl). 1996. PMID: 8880940
-
Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats.Psychopharmacology (Berl). 1994 Mar;114(2):369-74. doi: 10.1007/BF02244861. Psychopharmacology (Berl). 1994. PMID: 7838931
-
Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors.EMBO J. 1999 Mar 1;18(5):1235-44. doi: 10.1093/emboj/18.5.1235. EMBO J. 1999. PMID: 10064590 Free PMC article.
-
Nicotinic systems and cognitive function.Psychopharmacology (Berl). 1992;108(4):417-31. doi: 10.1007/BF02247415. Psychopharmacology (Berl). 1992. PMID: 1357713
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous